Immunomodulatory molecules in renal cell cancer: CD80 and CD86 are expressed on tumor cells
Anne Flörcken(Humboldt-Universität zu Berlin), Korinna Jöhrens(University Hospital Carl Gustav Carus)
MDC Repository (Max-Delbrueck-Center for Molecular Medicine)
February 15, 2017
Cited by 9
Related Papers
Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
|Journal of Hematology & Oncology|2022|58
Expression patterns of CD168 correlate with the stage and grade of squamous cell carcinoma of head and neck
|Molecular and Clinical Oncology|2017|9